Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Bibliographic Details
Main Authors:	Sakai, Ryoko, Cho, Soo-Kyung, Nanki, Toshihiro, Watanabe, Kaori, Yamazaki, Hayato, Tanaka, Michi, Koike, Ryuji, Tanaka, Yoshiya, Saito, Kazuyoshi, Hirata, Shintaro, Amano, Koichi, Nagasawa, Hayato, Sumida, Takayuki, Hayashi, Taichi, Sugihara, Takahiko, Dobashi, Hiroaki, Yasuda, Shinsuke, Sawada, Tetsuji, Ezawa, Kazuhiko, Ueda, Atsuhisa, Fujii, Takao, Migita, Kiyoshi, Miyasaka, Nobuyuki, Harigai, Masayoshi
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384380/

id	pubmed-4384380
recordtype	oai_dc
spelling	pubmed-43843802015-04-04 Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry Sakai, Ryoko Cho, Soo-Kyung Nanki, Toshihiro Watanabe, Kaori Yamazaki, Hayato Tanaka, Michi Koike, Ryuji Tanaka, Yoshiya Saito, Kazuyoshi Hirata, Shintaro Amano, Koichi Nagasawa, Hayato Sumida, Takayuki Hayashi, Taichi Sugihara, Takahiko Dobashi, Hiroaki Yasuda, Shinsuke Sawada, Tetsuji Ezawa, Kazuhiko Ueda, Atsuhisa Fujii, Takao Migita, Kiyoshi Miyasaka, Nobuyuki Harigai, Masayoshi Research Article BioMed Central 2015-03-23 2015 /pmc/articles/PMC4384380/ /pubmed/25880658 http://dx.doi.org/10.1186/s13075-015-0583-8 Text en © Sakai et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Sakai, Ryoko Cho, Soo-Kyung Nanki, Toshihiro Watanabe, Kaori Yamazaki, Hayato Tanaka, Michi Koike, Ryuji Tanaka, Yoshiya Saito, Kazuyoshi Hirata, Shintaro Amano, Koichi Nagasawa, Hayato Sumida, Takayuki Hayashi, Taichi Sugihara, Takahiko Dobashi, Hiroaki Yasuda, Shinsuke Sawada, Tetsuji Ezawa, Kazuhiko Ueda, Atsuhisa Fujii, Takao Migita, Kiyoshi Miyasaka, Nobuyuki Harigai, Masayoshi
spellingShingle	Sakai, Ryoko Cho, Soo-Kyung Nanki, Toshihiro Watanabe, Kaori Yamazaki, Hayato Tanaka, Michi Koike, Ryuji Tanaka, Yoshiya Saito, Kazuyoshi Hirata, Shintaro Amano, Koichi Nagasawa, Hayato Sumida, Takayuki Hayashi, Taichi Sugihara, Takahiko Dobashi, Hiroaki Yasuda, Shinsuke Sawada, Tetsuji Ezawa, Kazuhiko Ueda, Atsuhisa Fujii, Takao Migita, Kiyoshi Miyasaka, Nobuyuki Harigai, Masayoshi Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
author_facet	Sakai, Ryoko Cho, Soo-Kyung Nanki, Toshihiro Watanabe, Kaori Yamazaki, Hayato Tanaka, Michi Koike, Ryuji Tanaka, Yoshiya Saito, Kazuyoshi Hirata, Shintaro Amano, Koichi Nagasawa, Hayato Sumida, Takayuki Hayashi, Taichi Sugihara, Takahiko Dobashi, Hiroaki Yasuda, Shinsuke Sawada, Tetsuji Ezawa, Kazuhiko Ueda, Atsuhisa Fujii, Takao Migita, Kiyoshi Miyasaka, Nobuyuki Harigai, Masayoshi
author_sort	Sakai, Ryoko
title	Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
title_short	Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
title_full	Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
title_fullStr	Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
title_full_unstemmed	Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
title_sort	head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (ra) in clinical practice: results from the registry of japanese ra patients on biologics for long-term safety (real) registry
description
publisher	BioMed Central
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384380/
_version_	1613207312703422464

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Similar Items